Home
About
Platform
Pipeline
Patients
News
Contact
Investors
Newsroom
News and Press Releases
Press Releases
December 23, 2024
GlobeNewsWire
Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs
read more...
December 18, 2024
GlobeNewsWire
Neutrolis Expands Senior Leadership Team to Drive Development of Growing Pipeline of Non-Immunosuppressive Therapies for NET-mediated Autoimmune Diseases
read more...
In the News
March 10, 2025
citeline
Biotech Aims For NET Gains By Targeting Neutrophil Extracellular Traps
read more...
December 23, 2024
GlobeNewsWire
Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs
read more...
December 18, 2024
GlobeNewsWire
Neutrolis Expands Senior Leadership Team to Drive Development of Growing Pipeline of Non-Immunosuppressive Therapies for NET-mediated Autoimmune Diseases
read more...
